The Christie NHS FT Annual Report & Accounts 2019-20

The Christie NHS Foundation Trust Annual Report & Accounts 2019-20

• Remind staff of the importance of appropriate Capillary Blood Glucose (CBG) monitoring, recording results, and acting on results outside safe parameters - done via link nurses & Band 7 meeting. • Formal action plan created between receptionist and line manager in respect of attitude. • Re-introduction of consultant led Board Rounds to facilitate better communication and agreed plans of care between members of the Multi-Disciplinary Team. • Automated report to be run daily from Mosaiq and distributed to clinical oncology secretaries. • Communication to all secretarial staff of the importance of ensuring appointment letters are distributed in a timely manner at all times. On-The-Day Waiting Times We have continued to set ourselves the challenging target of ensuring that 80% of patients would wait no longer than one hour for their chemotherapy treatment The graph below show the performance of this target for 2019/20 (with the exception of August and September where a new system was put in place) and we continue to monitor this target.

Chemotherapy % seen within one hour

100%

75%

Apr Mar Standard 80% 80% 80% 80% 80% 80% 80% 80% 80% 80% 80% 80% 2018/19 92.3% 91.5% 91.2% 86.8% 85.7% 82.5% 85.5% 89.8% 85.5% 86.0% 89.5% 89.1% 2019/20 90.4% 90.7% 89.8% 90.4% 90.5% 89.3% 90.8% 89.9% 91.6% 90.4% 50% May Jun Jul Aug Sep Oct Nov Dec Jan Feb

Clinical indicators - Clinical Effectiveness. National and local clinical audits show that the care provided by The Christie is effective in prolonging life and reducing the pain and distress associated with cancer and its treatment. As described in our 2018/19 quality accounts outcomes such as mortality and complication rates after highly specialised, urological, gynaecological and colorectal surgery at The Christie have been reported to the board of directors and when published have set international benchmarks for standards of care. Similarly, outcomes of radiotherapy and chemotherapy for specific cancer types have shown care at The Christie to be of international standard. These results are published in professional journals and discussed at the Trust’s regular mortality and morbidity meetings. The board of directors receives a monthly presentation from a clinician describing a patient’s story including the outcomes and effectiveness of the care that they provide. The board of directors also

80